Shukur HY. Long term continuous Trastuzumab use for HER2-positive advanced breast cancer. J. Contemp. Med. Sci. [Internet]. 2020 Oct. 30 [cited 2024 May 16];6(5):234-41. Available from: https://www.jocms.org/index.php/jcms/article/view/862